Hhlr Advisors, Ltd. Talaris Therapeutics, Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.51 - $9.85 $1.95 Million - $4.26 Million	-432,643 Reduced 61.91%	266,154 $1.2 Million
Q1 2022 May 16, 2022	SELL	$6.89 - $16.56 $434,676 - $1.04 Million	-63,088 Reduced 8.28%	698,797 $6.88 Million
Q3 2021 Nov 15, 2021	SELL	$11.61 - $15.99 $1.06 Million - $1.46 Million	-91,459 Reduced 10.72%	761,885 $10.3 Million
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $10.5 Million - $15.9 Million	853,344 New	853,344 $12.5 Million

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.